KRW 5130.0
(-1.35%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 7.01 Billion KRW | -15.34% |
2022 | 8.29 Billion KRW | -0.64% |
2021 | 8.34 Billion KRW | -20.85% |
2020 | 10.54 Billion KRW | 656.28% |
2019 | 1.39 Billion KRW | -22.3% |
2018 | 1.79 Billion KRW | -16.48% |
2017 | 2.14 Billion KRW | 155.68% |
2016 | 840.23 Million KRW | 55.19% |
2015 | 541.44 Million KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 6.4 Billion KRW | 0.38% |
2024 Q1 | 6.37 Billion KRW | -9.11% |
2023 Q2 | 4.58 Billion KRW | -32.3% |
2023 FY | 7.01 Billion KRW | -15.34% |
2023 Q4 | 7.01 Billion KRW | 47.27% |
2023 Q3 | 4.76 Billion KRW | 4.05% |
2023 Q1 | 6.76 Billion KRW | -18.39% |
2022 Q2 | 30.92 Billion KRW | 13.69% |
2022 FY | 8.29 Billion KRW | -0.64% |
2022 Q4 | 8.29 Billion KRW | -71.14% |
2022 Q3 | 28.73 Billion KRW | -7.1% |
2022 Q1 | 27.2 Billion KRW | 225.97% |
2021 Q4 | 8.34 Billion KRW | 1.94% |
2021 Q2 | 8.92 Billion KRW | -14.06% |
2021 Q1 | 10.37 Billion KRW | -1.55% |
2021 FY | 8.34 Billion KRW | -20.85% |
2021 Q3 | 8.18 Billion KRW | -8.23% |
2020 Q3 | 11.29 Billion KRW | 19.68% |
2020 Q1 | 2.1 Billion KRW | 50.87% |
2020 FY | 10.54 Billion KRW | 656.28% |
2020 Q2 | 9.43 Billion KRW | 348.74% |
2020 Q4 | 10.54 Billion KRW | -6.66% |
2019 Q3 | 1.9 Billion KRW | 0.0% |
2019 FY | 1.39 Billion KRW | -22.3% |
2019 Q4 | 1.39 Billion KRW | -26.85% |
2019 Q1 | - KRW | -100.0% |
2018 Q4 | 1.79 Billion KRW | 0.0% |
2018 FY | 1.79 Billion KRW | -16.48% |
2017 FY | 2.14 Billion KRW | 155.68% |
2016 FY | 840.23 Million KRW | 55.19% |
2015 FY | 541.44 Million KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 15.04 Billion KRW | 53.352% |
InBody Co.,Ltd | 29.41 Billion KRW | 76.138% |
Curexo Inc. | 31.77 Billion KRW | 77.906% |
Seegene, Inc. | 137.63 Billion KRW | 94.9% |
i-SENS, Inc. | 83.54 Billion KRW | 91.597% |
Ray Co., Ltd. | 25.37 Billion KRW | 72.333% |
Gencurix Inc. | 581.02 Million KRW | -1108.15% |
L&C Bio Co., Ltd | 46.28 Billion KRW | 84.835% |